SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading HEB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-2.25%79.411.6%$919.01m
BIIBBiogen Inc.
0.31%289.931.2%$536.41m
CELGCelgene Corporation
0.86%112.221.1%$518.80m
AMGNAmgen Inc.
0.43%172.021.2%$490.82m
REGNRegeneron Pharmaceuticals, Inc.
3.43%425.123.1%$322.43m
ALXNAlexion Pharmaceuticals, Inc.
-1.38%128.602.6%$246.49m
BMRNBioMarin Pharmaceutical Inc.
1.24%99.423.9%$225.58m
ILMNIllumina, Inc.
-0.04%166.355.1%$194.87m
TSROTESARO, Inc.
-0.41%93.2418.0%$139.38m
VRTXVertex Pharmaceuticals Incorporated
0.82%97.001.7%$134.70m
MDVNMedivation, Inc.
2.40%63.992.6%$121.67m
EXASExact Sciences Corporation
0.35%17.3828.8%$111.63m
JUNOJuno Therapeutics, Inc.
3.41%30.937.9%$107.19m
AAgilent Technologies, Inc.
1.26%48.111.9%$84.25m
INCYIncyte Corporation
2.37%90.212.2%$73.84m

Company Profile

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.